{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:11:07Z","timestamp":1759407067541,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20fk0210033h0003","21fk0210083h0001","22fk0210083s0102"],"award-info":[{"award-number":["20fk0210033h0003","21fk0210083h0001","22fk0210083s0102"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K16680","22K07096"],"award-info":[{"award-number":["19K16680","22K07096"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001863","name":"New Energy and Industrial Technology Development Organization","doi-asserted-by":"publisher","award":["JPNP14033"],"award-info":[{"award-number":["JPNP14033"]}],"id":[{"id":"10.13039\/501100001863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004091","name":"Kumamoto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.vaccine.2023.09.026","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T16:00:01Z","timestamp":1695225601000},"page":"6514-6521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hybrid large hepatitis B surface protein composed of two viral genotypes C and D induces strongly cross-neutralizing antibodies"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-7762","authenticated-orcid":false,"given":"Takahiro","family":"Sanada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinatsu","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Isotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-5837","authenticated-orcid":false,"given":"Michinori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.09.026_b0005","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2023.09.026_b0010","unstructured":"World Health Organization. Hepatits B, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b; 2022 [accessed 10 May 2023]."},{"key":"10.1016\/j.vaccine.2023.09.026_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.04.005","article-title":"Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance","volume":"8","author":"Menendez-Arias","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2023.09.026_b0020","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.3748\/wjg.v21.i23.7074","article-title":"Unsolved problems and future perspectives of hepatitis B virus vaccination","volume":"21","author":"Tajiri","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2023.09.026_b0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0149-2918(01)80044-8","article-title":"Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines","volume":"23","author":"Coates","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2023.09.026_b0030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ki.1995.177","article-title":"Chronic viral hepatitis and the management of chronic renal failure","volume":"47","author":"Martin","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.vaccine.2023.09.026_b0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11904-019-00461-6","article-title":"Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV","volume":"16","author":"Farooq","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.vaccine.2023.09.026_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-3797(98)00003-8","article-title":"Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection","volume":"15","author":"Averhoff","year":"1998","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2023.09.026_b0045","first-page":"8","article-title":"Cross-Protection of Hepatitis B Vaccination among Different Genotypes","author":"Inoue","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.09.026_b0050","doi-asserted-by":"crossref","first-page":"2219347","DOI":"10.1080\/22221751.2023.2219347","article-title":"Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection\/quantification and vaccination strategies","volume":"12","author":"Piermatteo","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.09.026_b0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","article-title":"Hepatitis B virus PreS\/S gene variants: pathobiology and clinical implications","volume":"61","author":"Pollicino","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2023.09.026_b0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4161\/hv.34306","volume":"11","author":"Romano","year":"2015","journal-title":"Hepatitis B vaccination Hum Vaccin Immunother"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2023.09.026_b0065","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1099\/0022-1317-78-10-2639","article-title":"Altered antigenicity of 'a' determinant variants of hepatitis B virus","volume":"78","author":"Chiou","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2023.09.026_b0070","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2023.09.026_b0075","doi-asserted-by":"crossref","first-page":"9174","DOI":"10.1073\/pnas.83.23.9174","article-title":"A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees","volume":"83","author":"Itoh","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2023.09.026_b0080","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1038\/s41467-022-32910-z","article-title":"Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen","volume":"13","author":"Washizaki","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.09.026_b0085","article-title":"The genotype (A to H) dependent N-terminal sequence of HBV large surface protein affects viral replication","volume":"12","author":"Ou","year":"2021","journal-title":"Secretion and Infectivity Front Microbiol"},{"key":"10.1016\/j.vaccine.2023.09.026_b0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000360947","article-title":"Genotypes and genetic variability of hepatitis B virus","volume":"57","author":"Kramvis","year":"2014","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2023.09.026_b0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbrc.2019.09.072","article-title":"Intranasal vaccination with HBs and HBc protein combined with carboxyl vinyl polymer induces strong neutralizing antibody, anti-HBs IgA, and IFNG response","volume":"520","author":"Sanada","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2023.09.026_b0100","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0021-9258(18)46039-5","article-title":"Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization","volume":"267","author":"Kuroda","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2023.09.026_b0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0076-6879(87)54076-9","article-title":"5-Fluoroorotic acid as a selective agent in yeast molecular genetics","volume":"154","author":"Boeke","year":"1987","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2023.09.026_b0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pep.2011.04.008","article-title":"Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae","volume":"78","author":"Jung","year":"2011","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2023.09.026_b0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcmgh.2016.10.003","article-title":"Transmission of HBV DNA Mediated by Ceramide-Triggered Extracellular Vesicles","volume":"3","author":"Sanada","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2023.09.026_b0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0264-410X(89)90235-1","article-title":"Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective","volume":"7","author":"Neurath","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.09.026_b0125","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1172\/JCI114299","article-title":"The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man","volume":"84","author":"Ferrari","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2023.09.026_b0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4049\/jimmunol.137.1.315","article-title":"Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg","volume":"137","author":"Milich","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.09.026_b0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/viro.1993.1243","article-title":"Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier","volume":"194","author":"Fernholz","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2023.09.026_b0140","first-page":"11","article-title":"A Recent Prevalence of Hepatitis B Virus (HBV) Genotypes and Subtypes in Asia: A Systematic Review and Meta-Analysis","author":"Bello","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.vaccine.2023.09.026_b0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1007644","article-title":"Nucleic acid testing to detect HBV infection in blood donors","volume":"364","author":"Stramer","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.09.026_b0150","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00535-017-1316-3","article-title":"Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes","volume":"52","author":"Kato","year":"2017","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.vaccine.2023.09.026_b0155","doi-asserted-by":"crossref","first-page":"e27941","DOI":"10.1097\/MD.0000000000027941","article-title":"Distribution of hepatitis B virus genotypes and subgenotypes: A meta-analysis","volume":"100","author":"Liu","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2023.09.026_b0160","unstructured":"World Health Organization. Immunization coverage, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage; 2022 [accessed 15 May 2023]."},{"key":"10.1016\/j.vaccine.2023.09.026_b0165","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1038\/s41598-017-07085-z","article-title":"Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005\u20132013) in eastern China","volume":"7","author":"Yan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.09.026_b0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0140-6736(90)91874-A","article-title":"Vaccine-induced escape mutant of hepatitis B virus","volume":"336","author":"Carman","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.09.026_b0175","first-page":"12","article-title":"Hepatitis B virus (HBV) subviral particles as protective vaccines and vaccine platforms","author":"Ho","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.09.026_b0180","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/0264-410X(94)90178-3","article-title":"Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing","volume":"12","author":"Suzuki","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.09.026_b0185","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1016\/j.vaccine.2023.05.010","article-title":"The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine","volume":"41","author":"Vesikari","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.09.026_b0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2893.1996.tb00079.x","article-title":"Reactogenicity and immunogenicity of a new recombinant hepatitis B vaccine containing Pre S antigens: a preliminary report","volume":"3","author":"Hourvitz","year":"1996","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2023.09.026_b0195","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.vaccine.2006.01.007","article-title":"Comparative immunogenicity of a PreS\/S hepatitis B vaccine in non- and low responders to conventional vaccine","volume":"24","author":"Rendi-Wagner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.09.026_b0200","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/0264-410X(94)90155-4","article-title":"Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines","volume":"12","author":"Shouval","year":"1994","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23010964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23010964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:32:00Z","timestamp":1759404720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23010964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":40,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0264410X23010964"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.09.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybrid large hepatitis B surface protein composed of two viral genotypes C and D induces strongly cross-neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}